Suchergebnisse - "33E86K87QN"

PubPharm (116)

1

Protein phosphatase 6 regulates trametinib sensitivity, a mitogen-activated protein kinase kinase (MEK) inhibitor, by regulating MEK1/2-ERK1/2 signaling in canine melanoma cells

enthalten in: The Journal of veterinary medical science | 2023

von Yamamoto, M. | Fujiwara, N.

2

Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma

enthalten in: International journal of molecular sciences | 2023

von Krebs, F. | Moura, B. | Missiaglia, E. | +7

3

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS) : an international, randomised, open-label, multicentre, phase 2/3 trial

enthalten in: Lancet (London, England) | 2022

von Gershenson, D. | Miller, A. | Brady, W. | +23

CommentIn: Lancet. 2022 Feb 5;399(10324):499-501. - PMID 35123677

4

FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis

enthalten in: Cancer science | 2022

von Ando, K. | Ohira, M. | Takada, I. | +8

5

Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy

enthalten in: JCO precision oncology | 2022

von Remenár, �. | Dóczi, R. | Dirner, A. | +13

6

Molecular Management of Multifocal Atrial Tachycardia in Noonan's Syndrome With MEK1/2 Inhibitor Trametinib

enthalten in: Circulation. Genomic and precision medicine | 2021

von Meisner, J. | Bradley, D. | Russell, M.

7

Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme : A Case Report and Literature Review

enthalten in: Current problems in cancer | 2021

von Venkatesh, A. | Joshi, A. | Allinson, K. | +6

8

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma

enthalten in: Molecular cancer therapeutics | 2021

von Nassar, K. | Hintzsche, J. | Bagby, S. | +8

9

Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2021

von Kan, G. | Wang, Z. | Sheng, C. | +4

10

Comment on : Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib

enthalten in: Pediatric blood & cancer | 2021

von Vicenzi, P. | Ray, A.

CommentOn: Pediatr Blood Cancer. 2020 Dec;67(12):e28712. - PMID 32991018

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]